Safety and pharmacodynamics of rontalizumab in patients with systemic lupus erythematosus: results of a phase I, placebo-controlled, double-blind, dose-escalation study. (Q45943683)
Jump to navigation
Jump to search
scientific article published in November 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Safety and pharmacodynamics of rontalizumab in patients with systemic lupus erythematosus: results of a phase I, placebo-controlled, double-blind, dose-escalation study. |
scientific article published in November 2012 |
Statements
1 reference
Safety and pharmacodynamics of rontalizumab in patients with systemic lupus erythematosus: results of a phase I, placebo-controlled, double-blind, dose-escalation study. (English)
1 reference
Jacqueline M McBride
1 reference
Jenny Jiang
1 reference
Alexander R Abbas
1 reference
Alyssa Morimoto
1 reference
Jing Li
1 reference
Romeo Maciuca
1 reference
Michael Townsend
1 reference
Daniel J Wallace
1 reference
William P Kennedy
1 reference
Jorn Drappa
1 reference
1 November 2012
1 reference
1 reference
64
1 reference
3666-3676
1 reference
11
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference